Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-08-04
1990-09-18
Rivers, Diana G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544276, A61K 3152, C07D47316
Patent
active
049579240
ABSTRACT:
The present invention relates to certain amino acid exters of the purine nucleoside acyclovir, pharmaceutically acceptable salts thereof and their use in the treatment of herpes virus infections. The invention also includes pharmaceutical formulations and processes for the preparation of such compounds.
REFERENCES:
patent: 4199574 (1980-04-01), Schaeffer
patent: 4287188 (1981-09-01), Schaeffer
patent: 4294831 (1981-10-01), Schaeffer
patent: 4457919 (1984-07-01), Simon et al.
patent: 4548819 (1985-10-01), De Clercq et al.
patent: 4567182 (1986-01-01), Ferraris
patent: 4695570 (1987-09-01), Krenitsky
patent: 4745119 (1988-05-01), Krenitsky
Brown Donald
Burroughs Wellcome Co.
Green Hannah O.
Nielsen Lawrence A.
Rivers Diana G.
LandOfFree
Therapeutic valine esters of acyclovir and pharmaceutically acce does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic valine esters of acyclovir and pharmaceutically acce, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic valine esters of acyclovir and pharmaceutically acce will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1572879